## Abstract Previous studies indicate that calcium and its regulating hormones, __i.e__., parathyroid hormone (PTH) and vitamin D, might affect breast cancer risk. Evidence also suggests that this relationship could be influenced by menopausal status and BMI. We examined breast cancer risk related
Serum enterolactone concentration is not associated with breast cancer risk in a nested case-control study
✍ Scribed by Annamari Kilkkinen; Jarmo Virtamo; Erkki Vartiainen; Risto Sankila; Mikko J. Virtanen; Herman Adlercreutz; Pirjo Pietinen
- Publisher
- John Wiley and Sons
- Year
- 2003
- Tongue
- French
- Weight
- 73 KB
- Volume
- 108
- Category
- Article
- ISSN
- 0020-7136
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
The lignan enterolactone produced by the intestinal microflora from dietary precursors has been hypothesized to protect against hormone‐dependent cancers. We conducted a nested case‐control study to examine the relationship between serum enterolactone concentration and risk of breast cancer. Enterolactone concentrations were measured by time‐resolved fluoroimmunoassay in serum collected at 4 independent cross‐sectional population surveys from 206 women with breast cancer diagnosed during follow‐up (mean 8.0 years) and from 215 controls frequency‐matched to cases by study cohort, 5‐year age group and study area. Mean serum enterolactone concentration (nmol/l) did not significantly differ between case and control subjects [25.2 (SD 22.2) vs. 24.0 (SD 21.3), respectively]. Odds ratios for breast cancer risk estimated by conditional logistic regression for increasing concentration of enterolactone in quartiles were 1.00 (referent), 1.67 (95% CI 0.95–2.95), 1.71 (95% CI 0.96–3.06) and 1.30 (95% CI 0.73–2.31), and p for trend was 0.48. Our findings do not support the hypothesis that high serum enterolactone concentration is associated with reduced risk of breast cancer. © 2003 Wiley‐Liss, Inc.
📜 SIMILAR VOLUMES
## Abstract Increases in risk of breast cancer in successive generations of migrants to the United States from China and rapid temporal changes in incidence rates in China following social and economic changes clearly implicate environmental factors in the etiology of this disease. Case–control and
## Abstract Risk of breast cancer is increased in women with proliferative benign breast conditions. Most of these conditions, however, do not progress to breast cancer. The purpose of our study was to identify factors possibly associated with this progression. Women with proliferative fibrocystic
There is concern that hormone replacement therapy (HRT) increases the risk of breast cancer. We undertook a casecontrol study of this risk relationship within a cohort of 40-to 74-year-old women in Uppsala County, Sweden, who participated in mammography screening. Incident cases of breast cancer wer
## Abstract Pancreatic adenocarcinoma is one of the deadliest cancers with mortality rates almost equaling incidence rates. Each year, approximately 3,500 Canadians are diagnosed with this disease. Although somewhat inconsistent, epidemiological studies have found that allergies are associated with